Cas:23299-85-6 Bis[1-(2-pyridylazo)-2-naphtholato]copper(II) manufacturer & supplier

We serve Chemical Name:Bis[1-(2-pyridylazo)-2-naphtholato]copper(II) CAS:23299-85-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Bis[1-(2-pyridylazo)-2-naphtholato]copper(II)

Chemical Name:Bis[1-(2-pyridylazo)-2-naphtholato]copper(II)
CAS.NO:23299-85-6
Synonyms:Cu(PAN)2;Cu(1-(2-pyridylazo)-2-naphthol)2;Copper PAN
Molecular Formula:C30H20CuN6O2
Molecular Weight:560.06500
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:93.68000
Exact Mass:559.09400
LogP:6.72650

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Cu(PAN)2 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Copper PAN physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Copper PAN Use and application,Copper PAN technical grade,usp/ep/jp grade.


Related News: Founded in 1949 by Giovanni Stevanato, the packaging multinational is the world’s largest maker of cartridges for insulin pens and provides vials and syringes for 90% of the world’s Covid-19 vaccines. 6-(trifluoromethyl)-2-(4-(3-(trifluoromethyl)pyridin-2-yl)piperazin-1-yl)-1H-benzo[d]imidazol-4-amine manufacturers So-called “off” periods occur when a Parkinson’s patient has difficulty moving about and occur when the effect of the last dose of another common Parkinson’s drug, known as levodopa, wears off. 3-Formyl-piperidine-1-carboxylic acid ethyl ester suppliers EMA said it considered that the results of the clinical studies used to support the application “were inconsistent and did not satisfactorily show that Nouryant was effective at reducing the ‘off’ time. 5-Acetylhexahelicen vendor & factory As Natural Capsules did not have access to this manufacturing technology, its R&D centre, which is DSIR approved, had started working on the same since 2018, and has now successfully developed the process including fermentation and chemical synthesis steps, Sunil Mundra, managing director, Natural Capsules told Pharmabiz.,Founded in 1949 by Giovanni Stevanato, the packaging multinational is the world’s largest maker of cartridges for insulin pens and provides vials and syringes for 90% of the world’s Covid-19 vaccines.